Mixed tumors of the vagina (MTsV), also recently designated as spindle cell epitheliomas, 1 are rare tumors. Since the first description of this tumor in 1953, 2 no more than 50 cases have been reported in the English language literature to the best of our knowledge. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] In other anatomic locations, the term mixed tumor is typically used to designate a neoplasm composed of epithelial and myoepithelial cells. Those occur most frequently in the salivary gland; [18] [19] [20] however similar tumors have been reported in the breast, 21, 22 skin, 23 vulva, 24 external auditory canal, 25 trachea, 26 lacrimal gland, 27 and soft tissue. 28 In contrast, MTsV show a different histo logic appearance and myoepithelial cells are not known to exist either in the vagina or in vaginal glandular inclusions. There is no clear origin of these tumors, although several relatively recent studies have proposed an origin from urogenital sinus-derived epithelium based upon the high frequency of these neoplasms near the hymenal ring and strong immunohistochemical and ultrastructural evidence for an epithelial origin. 1, 3, 7 The purpose of this study was to investigate the immunohistochemical profile of these tumors, in order to contribute to knowledge of their histogenesis and also to see if their immunohistochemical profile may be useful in their differential diagnosis.
Materials and methods
Tissue blocks of 13 MTsV were retrieved from the consultation files of one of us (RHY) and Dr Robert E Scully, and from the archives of the Massachusetts General Hospital. After confirmation of the diagnosis by examination of 4-mm hematoxylin and eosin-stained slides (Figure 1a ), paraffin-embedded tissue for each case was deparaffinized and subjected to heat-induced epitope antigen retrieval using an electric pressure cooker set at 1201C for 5 min. Sections were incubated for 5 min in 3% hydrogen peroxide to quench endogenous tissue peroxidase. As the tissue source was primarily from consultation material from different hospitals, tissue fixation may have varied. Immunohistochemistry Mixed tumors of the vagina E Oliva et al was performed using the avidin-biotin-complex kit (Dako Corp., Carpinteria, CA, USA). The source and dilution of antibodies are shown in Table 1 .
Immunohistochemical stains were performed for cytokeratin 7 (CK7), cytokeratin 20 (CK20), epithelial membrane antigen (EMA), h-Caldesmon, and CD10 in 13 specimens, AE1/3 and smooth muscle actin in 12 cases, desmin and CD34 in 11 cases, CD99 in eight, and S100 in seven specimens. Scoring was based upon the percentage of positive tumor cells in the epithelial and stromal-like components. However, five tumors did not have a clearcut epithelial component in the block available for immunohistochemistry. The intensity of the immunostaining was graded as 1 þ to 3 þ . Tumors in which rare scattered cells (o5%) were immunoreactive for specific markers were recorded as such but were considered negative. Although the stromallike cells of these tumors may be epithelial in derivation in this presentation for clarity sake, the overt epithelial areas are referred to as 'epithelial' and the spindle cell areas as 'stromal-like'.
Results
The immunohistochemical results are summarized in Table 2 Desmin stained 10 out of 11 tumors. Only one out of the seven tumors with an epithelial component present in the section for evaluation had positivity of the epithelial component (30%, 2 þ ) and 10 tumors showed positivity in the stromal-like component, with an intensity ranging from 2 þ to 3 þ (seven being 3 þ ) in 5-70 % of the tumor cells (seven tumors had 425% positive cells). In one tumor, the expression of desmin in the stromal-like component was o1%, and was considered negative. One tumor showed desmin in both epithelial and stromal-like components.
h-Caldesmon was expressed in five out of 13 tumors (Figure 1d 
Discussion
Although MTsV are well-known benign neoplasms, their histogenesis is still controversial. MTsV should be distinguished from mixed tumors at other sites, as the latter have a common origin from myoepithelial cells, and retain variable degrees of myoepithelial differentiation. [19] [20] [21] [23] [24] [25] [26] [27] [28] These features are lacking in MTsV, even though initial reports supported a myoepithelial origin for these tumors by immunohistochemistry and/or ultrastructure. 4, 13 Recent studies have supported an epithelial origin of MTsV, favoring a urogenital sinus over a mullerian origin given the typical location around the hymenal ring and the likehood of epithelial migration during vaginal embryogenesis. 1, 9 Yet, it is of note that in most cases, the bulk of the tumor is composed of cells with a mesenchymal appearance, and that coexpression of actin and cytokeratin has been documented in a variety of tumors, not only pure epithelial tumors but also stromal predominant tumors. Finally, others have suggested that both the epithelial and stromal-type cells in MTsV may have an origin from a single multipotential cell, 8 as discussed in the first series of MTsV reported by Sirota and colleagues more than 20 years ago. 3 To date only one sizable study 1 and a few individual cases of MTsV 6-9,13,17 have been reported with relatively extensive immunohistochemical results (Table 3 ). We undertook this study to further delineate the immunohistochemical profile of MTsV in an attempt to elucidate the cell of origin and furthermore, to find out if there is a specific immunoprofile associated with MTsV that may help in distinguishing them from cellular smooth muscle tumors or other rarer tumors that may involve the vagina such as endometrial (endometrioid) stromal sarcoma particularly when dealing with small biopsy specimens or when the epithelial component is minimal and may be overlooked.
Keratins, initially used in the differential diagnosis of epithelial tumors with other neoplasms, mainly those of mesenchymal origin, may be positive in the latter including smooth muscle tumors and endometrial stromal tumors. [29] [30] [31] [32] [33] The largest immunohistochemical analysis of MTsV reported by Branton and Tavassoli 1 found intense reactivity with AE1/3 in nine out of 10 MTsV, while another tumor only showed sparse reactivity in the stromal-like component that was by far the predominant and in some cases the only component in these tumors. Similar results have been reported by others. 4, [6] [7] [8] [9] 13, 17 Our study also showed that 8/12 MTsV were positive for AE1/3, being positive in the stromal-like areas in 8/12 tumors. However, as mentioned earlier, as keratins may be positive in mesenchymal tumors they are not definitive in identifying the origin of these tumors nor in the differential diagnosis with other vaginal tumors with a mesenchymal component specifically smooth muscle tumors and endometrioid (endometrial) stromal tumors.
CK7 is mainly expressed in myoepithelial cells and simple epithelia. 29 In the vagina, squamous cell carcinoma expresses CK 7. Skelton and Smith 8 reported intense but not diffuse positivity for CK7 in a MTV that was only composed of spindle cells and Murdoch et al 17 reported CK7 positivity in both epithelial and stromal-like components. Our findings revealed that seven out 13 MTsV were CK7 positive, but mostly focally. This degree of positivity is not meaningful to postulate an epithelial origin of these tumors. Furthermore, positivity has also been reported in nonepithelial tumors including synovial Mixed tumors of the vagina E Oliva et al sarcoma, 34 epithelioid angiosarcoma, 33 and Wilms' tumor, the latter a neoplasm composed of primitivepluripotential cells. 35 Regarding CK20, we only found CK20 positive cells in two out of 13 MTsV and Skelton and Smith found minimal staining in the neoplasm they studied. Consequently, CK20 is not useful in the diagnosis or identifying the origin of MTsV.
EMA reacts with most epithelia and epithelial neoplasms 36 but it is also expressed in nonepithelial tumors including smooth muscle tumors, more commonly those of the genital tract, 31 and also in tumors with divergent differentiation such as synovial sarcomas 37 and desmoplastic small round cell tumors. 38 MA and desmin are two well-known markers of smooth muscle differentiation, although not 100% specific as they also stain myoepithelial cells and myoepithelial tumors and much less frequently epithelial neoplasms. The two MTsV reported by Skelton and Smith 8 and Nakashima et al 6 showed negative and minimal staining for MA respectively. However, Branton and Tavassoli 1 noted intense smooth muscle actin positivity in all their tumors, and Murdoch et al 17 showed actin positivity in the intermixed bundles of spindle cells. Our study also showed extensive MA positivity in 11 out of 12 MTsV, mainly in the stromal-like component. Desmin was negative in the tumors reported by Skelton and Smith 8 and Fukunaga et al, 7 and although we found desmin positivity in 10/11 MTsV studied, this was mainly in the stromal-like component as seen in the MTV reported by Murdoch et al. 17 These results may speak in favor of a myoepithelial origin for these neoplasms but do not exclude others, and they are not helpful in differentiating MTsV from other spindle cell tumors of the vagina.
h-Caldesmon, a smooth muscle marker thought to be restricted to vascular and visceral smooth muscle cells and myoepithelial cells, has not been previously studied in MTsV. Five out of 13 MTsV in this series showed focal h-Caldesmon positivity. This finding suggests again the possibility of a myoepithelial origin of MTsV, but one would expect the expression of this antibody to be more extensive and present in the majority of the tumors if they were of myoepithelial origin. The extent of positivity for h-Caldesmon in these tumors makes this antibody not useful in the differential diagnosis of MTsV with other vaginal tumors with a mesenchymal component. 39 although mixed tumors of the salivary gland are negative. In the female genital tract, CD10 reacts with endocervical and endometrial stromal cells, Wolffian remnants, and luteinized cells as well as with benign and malignant endocervical glandular lesions, endometrial adenocarcinomas, mullerian mixed tumors, endometrial stromal tumors, smooth muscle tumors, Wolffian tumors and sex-cord stromal tumors of the ovary. [39] [40] [41] [42] [43] [44] Our findings revealed extensive CD10 positivity in all MTsV (13 out of 13). To date, only one other very recent case report has shown CD10 positivity in MTsV. 17 This finding is not helpful regarding the histogenesis of these tumors, because as mentioned earlier, CD10 is negative in tumors derived from myoepithelial cells and CD10 has been seen in both epithelial and nonepithelial tumors. Furthermore, CD10 is not useful in distinguishing MTsV from smooth or skeletal muscle tumors, or even endometrioid (endometrial) stromal tumors that can occur at this site. With regard to the latter differential, this study was prompted in part by a case sent in consultation to one of us in which the patient had a previous history of an endometrial stromal sarcoma of the uterus and presented later with a vaginal nodule. The differential diagnosis in that case included recurrent endometrial stromal sarcoma with epithelial differentiation and MTV. That issue led to us investigating whether CD10 was a reliable discriminant.
Several studies have shown CD34 reactivity in smooth muscle tumors and other mesenchymal lesions, but malignant epithelial tumors are almost always negative. 45 In the female genital tract, CD34 is expressed in cervical stromal cells, basally located endometrial stromal cells and rare smooth muscle tumors, but it is negative in endometrial stromal sarcomas and aggressive angiomyxomas. 41 46 postulated that CD34 reactivity may be an inherent property of subsets of fibroblasts such as those of uterine stromal tissues, and although not all tumors in this series were CD34 positive, the presence of positivity in half of them may favor a mesenchymal origin of these tumors. As smooth muscle tumors may be positive for CD34, this antibody is not helpful in distinguishing MTsV from this tumor.
CD99, a sensitive marker of Ewing's sarcoma and peripheral primitive neuroectodermal tumors, is also expressed in epithelial and mesenchymal tumors, and those with divergent differentiation. 30, 38 In the female genital tract, it may be positive in ovarian sex-cord stromal tumors, 50, 51 uterine tumors resembling ovarian sex-cord tumors and smooth muscle tumors. 41, 52 Skelton and Smith 8 reported diffuse positivity for CD99 in one MTV. We found CD99 cytoplasmic expression in seven MTsV (10-60%), but none of the tumors showed the typical membranous staining.
Finally, S-100, initially considered specific to glial cells, has been found in other types of cells, such as myoepithelial cells, melanocytes, chondrocytes, adypocites, striated muscle, and weakly in some epithelial cells. 53 All MTsV previously reported were S-100 negative. Our results showed focal immunoreactivity in only one out of seven MTsV and argue against a myoepithelial origin for these neoplasms.
In conclusion, although positivity for CK7, MA, desmin and h-Caldesmon could favor a myoepithelial origin, S-100 negativity and diffuse CD10 positivity argues against it. An epithelial origin, suggested by some authors, is not certain as these tumors extensively express several mesenchymal markers. Our immunohistochemical results, in which stromal-type cells and epithelial cells coexpress different epithelial and mesenchymal markers, support the contention that MTsV may arise from a pluripotential cell that must have the ability to differentiate in both epithelial and mesenchymal directions. Their immunohistochemical profile is neither specific nor helpful in the differential diagnosis of MTsV from the more common vaginal smooth muscle tumors or even from other rare tumors. The final diagnosis must be based on a careful conventional microscopic evaluation of these neoplasms.
